InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled “Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2030” According to company’s newest research, the Global DNA and Gene Cloning Services Market is worth US$ 2.80 Billion in 2021 and is predicted to reach US$ 12.15 Billion in 2030, with a promising CAGR of 18.22% between 2022 and 2030.
Many scientific processes begin with gene synthesis and cloning. DNA amplification by subcloning and polymerase chain reaction are two standard techniques for genetic cloning. The method of DNA cloning is simply recombinant DNA technology, which combines DNA from two organisms into a single molecule. This recombinant DNA is inserted into the desired organism to produce hybrid offspring. DNA Cloning is used for protein production, gene analysis, and Gene Therapy. The method of cloning genes involves isolating all of an organism’s DNA and then locating and copying (or “cloning”) a specific gene of interest from that DNA. DNA Cloning includes DNA extraction of plasmid, restriction enzymes, and a living cell for multiplication of newly formed DNA. Polymerase chain Reaction(PCR) is widely used for cloning purposes. In genetic engineering, “gene cloning” refers to creating synthetic copies of a gene. Cloning genes can be done in two ways, in vivo and in vitro. Many human genes have been successfully cloned in E. coli or yeast, enabling the production of an infinite number of human proteins in vitro. More than 100 drugs for human therapy are manufactured using cultured cells (E. coli, yeast, and mammalian cells) modified with a human gene. Cloning is a revolutionary technique in the field of biotechnology. It is helping humanity in several ways, and many chronic diseases are being treated using this technique, increasing the lifespan. A healthy and better life is achieved due to this genetic development. In agricultural applications, crops are being improved daily, leading to better nutritious values.
The market for DNA and gene cloning services is expected to grow progressively in the coming years. This is due to the growing acceptance of gene therapies and the development and application of novel, cutting-edge DNA cloning technology. These two things will be likely to drive the market for DNA and gene cloning services. The market is also propelled by an increase in the number of firms entering the area and research and development spending, the rising prevalence of chronic and hereditary diseases, coupled with a growing need for personalized medicine. A favourable funding framework for gene synthesis and cloning services, technological advancements in cloning and subcloning services, and increased synergistic market activities are among the aspects driving the industry’s expansion during the forecast period.
In the coming years, the worldwide market for gene synthesis may be hampered by a lack of qualified personnel and rigorous and time-consuming approval procedures. Technological advancements, strategic partnerships, and acquisitions in the biomedical and healthcare industries might present the market with intriguing opportunities. However, High investments, funding, and collaborations for industrial growth are expected in the projection period as North America prioritizes the usage of DNA and Gene Cloning in the life science research industry.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
The significant market companies are Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene, Twist Bioscience, Thermo Fisher Scientific Inc., Eurofins Scientific, GenScript, Merck KGaA, Takara Bio Inc., Lonza, Sartorius AG, Creative Biogene, Cellecta, Inc., Synbio Technologies, TransGen Biotech Co., Ltd., Dobuss (Canvax), Azenta US, Inc., Macrogen, Inc., Codex DNA, Inc., Bio-Rad, and other key players.
Source: Bloomberg
